Navigation Links
False Claims Act Attorney Tim Terry to Address Arizona Chapter of the Association of Certified Fraud Examiners
Date:5/15/2010

False Claims Act Attorney Tim Terry of Carson City, Nevada, will participate in a panel of speakers at the Spring Seminar of the Arizona Chapter of the Association of Certified Fraud Examiners on May 17. Terry will discuss the "nuts and bolts" of the False Claims Act (FCA), its use in fighting fraud against the Government, and its unique Qui Tam provisions.

Phoenix, AZ (PRWEB) May 15, 2010 -- False Claims Act (FCA) attorney Tim Terry of Carson City, Nevada, will participate as a speaker at the Spring Seminar of the Arizona Chapter of the Association of Certified Fraud Examiners on May 17, 2010. The seminar is being conducted at the Arizona Industrial Commission offices at 800 W. Washington Street in Phoenix. Terry will highlight the provisions of the False Claims Act, its unique "Qui Tam" section, and how it is used in fighting fraud against the Government.

Terry represents False Claims Act "Relators" (also known as Whistleblowers) in cases involving Medicare fraud, Medicaid fraud, pharmaceutical fraud, economic stimulus program fraud, and other False Claims Act (FCA) prosecutions. The unique Qui Tam provisions in the False Claims Act permit private citizens who have knowledge of fraud against Government programs to help the Government in recovering ill-gotten gains and additional civil penalties. The False Claims Act allows the Government to collect up to three times the dollar amount it was defrauded, in addition to civil penalties ranging up to $10,000 per false claim. And, Terry noted, the Relator or Whistleblower normally receives a percentage of the Government's recovery for his or her efforts in assisting the Government.

Terry, who served for over 17 years as the head of the Medicaid Fraud Control Unit in the Nevada Attorney General's Office, was involved in over 100 False Claims Act cases and was a leading prosecutor of such cases under the
'/>"/>

Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Page: 1 2

Related medicine news :

1. Parent Company of Two New Jersey Hospitals to Pay U.S. $7.95 Million to Settle False Claims Act Allegations
2. Three New York City Home Health Agencies Pay $9.7 Million to the United States to Settle False Claims Act Claims
3. $24 Million Settlement of New York State and Federal False Claims Act Case
4. Oklahoma Hospital Group Pays U.S. $13 Million to Settle False Claims Act Allegations
5. Visiting Physicians Association to Pay $9.5 Million to Resolve False Claims Act Allegations
6. Michigan Health Care Provider to Pay United States $669,413 to Settle False Claims Allegations
7. Some Myths About Dogs and Cats Are Not Only False - Theyre Dangerous!
8. Great Salt Lake Chapter of National Contract Management Association Hosts Presentation on False Claims Act by Qui Tam Attorney Tim Terry
9. Massachusetts Hospital Agrees to Pay U.S. $2.79 Million to Resolve False Claims Act Allegations
10. Two Atlanta-Based Nursing Home Chains and Their Principals Pay $14 Million to Settle False Claims Act Case
11. Chicago Hospital to Pay More Than $1.5 Million to Resolve Medicare False Claims Act Allegations
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
False Claims Act Attorney Tim Terry to Address Arizona Chapter of the Association of Certified Fraud Examiners 
(Date:5/19/2013)... (PRWEB) May 19, 2013 Farming methods ... seed in the ground 10,000 years ago. Most recently, ... farm productivity by using genetically engineered seeds and by ... seeing a backlash to these techniques due to the ... chemicals and a corresponding surge in interest in organic, ...
(Date:5/19/2013)... Angeles (PRWEB) May 19, 2013 Yeast infections ... can appear in sensitive areas of the human body. A ... Yeastrol. This new formula provides a unique method of application ... new spray solution is now provided to men and women ... is naturally absorbed in the body through food and is ...
(Date:5/19/2013)... (PRWEB) May 19, 2013 Beginning Wednesday, May ... Valley Blood Center (RRVBC) will feature “Hot Dog Wednesdays" and ... RRVBC will provide hot dogs and all the fixin's ... slushies each day throughout the summer. “Donors are our lifeline. ... a stable and adequate blood supply. This is a ...
(Date:5/19/2013)... fender benders and serious car accidents are common sights ... to respond appropriately to the situation. According to ... 2010, accidents, including car accidents, are the fifth leading ... automobile accident-related deaths cost over $70 billion ... and passengers receive treatment in an emergency room every ...
(Date:5/18/2013)... COOLA, British Columbia (PRWEB) May 19, 2013 ... to Cooking” (published by iUniverse) , author Janet Hall Svisdahl’s ... delectable world recipes sure to make even the pickiest ... living peacefully, pleasurably and prayerfully,” she explains. , Found ... Spirit” are a wide range of delicious recipes, from fast ...
Breaking Medicine News(10 mins):Health News:Green Acre Aquaponics Introduces a Revolutionary Approach to Farm Education and Commercial Aquaponics 2Health News:Green Acre Aquaponics Introduces a Revolutionary Approach to Farm Education and Commercial Aquaponics 3Health News:A Safe & Homeopathic Yeast Infection Relief by Yeastrol Now Available at HealthCareSupplementz.com with Massive Discount 2Health News:Hot Dog Wednesdays and Ice Cold Slushies Return to Rock River Valley Blood Center for the Summer 2Health News:Auto Accident Infographic Issued by d’Oliveira & Associates on Steps to Take After a Car Crash 2Health News:Janet Hall Svisdahl Announces Release of ‘Cooking with Spirits for the Spirit’ 2
... Two methods that permit scientists to examine ... months release of Cold Spring Harbor Protocols . ... www.cshprotocols.org ), describe how to fluorescently tag cells in ... sophisticated imaging methods, permit scientists to visualize even subtle ...
... Splash with Las Vegas and Tucson Marathon Runners, ... ibuprofen,before an event to prevent inflammation and pain, but ... studies by researchers at,Appalachian State University and Vanderbilt University, ... that taking ibuprofen,before exercise may be unhealthy in the ...
... 3 As momentum continues to,build on the ... in Medicare, the Pharmaceutical Care Management Association,(PCMA) today ... J. Lyle,Bootman, Ph.D., Sc.D., Last year, Dr. ... recommended that all physicians begin using e-prescribing by,2010 ...
... Home Front Needs of Families with Deployed Service Members ... ... Alliance will present $15,000 to the Missouri National Guard -,Missouri Military Family Relief ... and their families., Don Brown, market vice president for the central market ...
... HUNTSVILLE, Ala., Dec. 3 Operon,Biotechnologies, Eurofins MWG ... Genomics network - announced today that they have ... new worldwide leader in the competitive,custom oligonucleotide market. ... of,the art high-throughput production facilities in all major ...
... and CEO retires; Mike Gallagher, President and ... MIAMI, Dec. 3 AvMed Health Plans ... announced plans to retire December 31,2007. As a ... parent company,SantaFe HealthCare, who already has overall leadership ...
Cached Medicine News:Health News:Cold Spring Harbor Protocols features innovative methods for embryology research 2Health News:Marathoners Share Tom Brady and LaDainian Tomlinson Pain Relief Affinity 2Health News:TriWest Contributes $15,000 to Missouri National Guard Fund 2Health News:MWG and Operon Are Joining Forces 2Health News:AvMed Announces Senior Leadership Changes 2
(Date:5/17/2013)... 17, 2013 Fuse Science, Inc. (OTCQB: DROP), ( ... is developing new, patent-pending technologies poised to redefine how consumers ... will hold a business update teleconference and webcast for shareholders ... 2013 at 4:30 PM ET. Fuse Science, ... the call and will be joined by Rubin ...
(Date:5/17/2013)... May 17, 2013  Sanofi (EURONEXT: SAN and NYSE: ... JAKARTA , examining the selective JAK2 ... in both dose groups. The primary endpoint assessed the ... Consistent with data reported in previous trials, the most ... Full results will be presented at an upcoming medical ...
(Date:5/16/2013)... and ZURICH , May 17, 2013 /PRNewswire/ ... Science, Technology and Research (A*STAR) and Switzerland,s ... volunteer has been dosed in a Phase 1 clinical trial ... bacteriophage Qbeta virus-like particle (VLP) technology. In this first Phase ... vaccine candidate and its potential to protect against H1N1 influenza ...
Breaking Medicine Technology:Fuse Science, Inc. to Hold Business Update Webcast and Teleconference on May 22nd 2Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 2Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 3Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 4Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 5Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 6A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 2A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 3A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 4A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 5A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 6
... Scientific,Corporation (NYSE: BSX ) today announced ... press announcements at the Cardiovascular Research Foundation,s,(CRF) ... which runs from October 20 to 25 ... be announcing a wide range of safety ...
... the novel,selective relaxant binding agent (SRBA) being developed ... neuromuscular blockade as,compared to neostigmine in the Phase ... Spectrum, faster recovery from profound neuromuscular,blockade compared to ... were presented today at the 2007 annual meeting ...
Cached Medicine Technology:Boston Scientific to Release Broad Range of Clinical Trial Data Reinforcing Safety and Efficacy of Taxus(R) Coronary Stent Systems at TCT 2007 2Boston Scientific to Release Broad Range of Clinical Trial Data Reinforcing Safety and Efficacy of Taxus(R) Coronary Stent Systems at TCT 2007 3Boston Scientific to Release Broad Range of Clinical Trial Data Reinforcing Safety and Efficacy of Taxus(R) Coronary Stent Systems at TCT 2007 4Boston Scientific to Release Broad Range of Clinical Trial Data Reinforcing Safety and Efficacy of Taxus(R) Coronary Stent Systems at TCT 2007 5Boston Scientific to Release Broad Range of Clinical Trial Data Reinforcing Safety and Efficacy of Taxus(R) Coronary Stent Systems at TCT 2007 6Boston Scientific to Release Broad Range of Clinical Trial Data Reinforcing Safety and Efficacy of Taxus(R) Coronary Stent Systems at TCT 2007 7Sugammadex Trials Demonstrate Rapid Recovery from Profound Neuromuscular Blockade During General Anesthesia 2Sugammadex Trials Demonstrate Rapid Recovery from Profound Neuromuscular Blockade During General Anesthesia 3Sugammadex Trials Demonstrate Rapid Recovery from Profound Neuromuscular Blockade During General Anesthesia 4Sugammadex Trials Demonstrate Rapid Recovery from Profound Neuromuscular Blockade During General Anesthesia 5
Inquire...
Inquire...
Inquire...
Inquire...
Medicine Products: